This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Adult-onset IBD linked to higher mortality While the onset of inflammatory bowel disease (ulcerative ... (17 May 2019)
Children who walk to school less likely to ... Children who regularly walk or cycle to school are less likely ... (20 May 2019)
Women with sleep apnoea are more likely to ... A study of more than 19,000 people has found that women with ... (20 May 2019)
Passion trumps love for sex in relationships When women distinguish between sex and the relational and ... (17 May 2019)
Inflammatory Bowel Disease During Childhood ... A new study revealed an increased risk of cancer and early death ... (13 May 2019)

New Glaucoma Procedure Performed in Malta

Rate this item
(0 votes)

On the 15th June, a new glaucoma procedure was performed for the first time in Malta, as part of a surgeon training session organised by Allergan. The new XEN implant forms part of Allergan’s Eyecare portfolio distributed by Vivian Corporation.

glaucoma 2

 

XEN is a simple and effective way to treat glaucoma. The implant consists of a small tube 6mm long and the thickness of a human hair, which is inserted into the eye with a pre-packed injector. This reduces the size of the incision needed. XEN is indicated to reduce eye pressure in patients whose glaucoma is not well-managed with eye drops. It is designed to stay in the eye permanently creating a small pathway to drain fluid away to lower pressure inside the eye.

The surgeons and staff first received training on artificial eyes at St. James Eye Clinic by Allergan’s surgical partner, Dr. Evelina Kotseva. The following morning, a total of 5 patients had the new XEN implants inserted into their eyes. These surgeries were performed by Mr. Mario Vella and Mr. Francis Carbonaro, at Mater Dei Hospital. Katrine Agius, Allergan’s Country Lead, said: "It is a very safe and less time-consuming alternative to the more traditional glaucoma surgery. XEN is also more cost-effective than using more than one type of glaucoma eye drops per patient".

Read 3345 times

Vivian

Highlights

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…